These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 12712363)

  • 1. Epidemiology of prostatitis: new evidence for a world-wide problem.
    Krieger JN; Riley DE; Cheah PY; Liong ML; Yuen KH
    World J Urol; 2003 Jun; 21(2):70-4. PubMed ID: 12712363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification, epidemiology and implications of chronic prostatitis in North America, Europe and Asia.
    Krieger JN
    Minerva Urol Nefrol; 2004 Jun; 56(2):99-107. PubMed ID: 15195020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH.
    Nickel JC; Elhilali M; Vallancien G;
    BJU Int; 2005 Mar; 95(4):571-4. PubMed ID: 15705082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The overlapping lower urinary tract symptoms of benign prostatic hyperplasia and prostatitis.
    Nickel JC
    Curr Opin Urol; 2006 Jan; 16(1):5-10. PubMed ID: 16385194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk.
    Hung SC; Lai SW; Tsai PY; Chen PC; Wu HC; Lin WH; Sung FC
    Br J Cancer; 2013 May; 108(9):1778-83. PubMed ID: 23612451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiologic risk factors for chronic prostatitis.
    Ku JH; Kim SW; Paick JS
    Int J Androl; 2005 Dec; 28(6):317-27. PubMed ID: 16300663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of inflammatory prostatitis on the development and progression of benign prostatic hyperplasia: A literature review.
    Tsunemori H; Sugimoto M
    Int J Urol; 2021 Nov; 28(11):1086-1092. PubMed ID: 34342061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic prostatitis--risk factor in development of prostatic cancer (review)].
    Mazo EB; Kozdoba AS
    Ter Arkh; 2007; 79(10):66-73. PubMed ID: 18154149
    [No Abstract]   [Full Text] [Related]  

  • 9. Sexually transmitted diseases and other urogenital conditions as risk factors for prostate cancer: a case--control study in Wayne County, Michigan.
    Patel DA; Bock CH; Schwartz K; Wenzlaff AS; Demers RY; Severson RK
    Cancer Causes Control; 2005 Apr; 16(3):263-73. PubMed ID: 15947878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexual behavior, sexually transmitted diseases and prostatitis: the risk of prostate cancer in black men.
    Sarma AV; McLaughlin JC; Wallner LP; Dunn RL; Cooney KA; Schottenfeld D; Montie JE; Wei JT
    J Urol; 2006 Sep; 176(3):1108-13. PubMed ID: 16890703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH.
    Seftel A
    J Urol; 2005 Nov; 174(5):1939. PubMed ID: 16217352
    [No Abstract]   [Full Text] [Related]  

  • 12. Racial differences in the relationship between clinical prostatitis, presence of inflammation in benign prostate and subsequent risk of prostate cancer.
    Rybicki BA; Kryvenko ON; Wang Y; Jankowski M; Trudeau S; Chitale DA; Gupta NS; Rundle A; Tang D
    Prostate Cancer Prostatic Dis; 2016 Jun; 19(2):145-50. PubMed ID: 26620738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autopsy study of prostatic weight and lesions in LUTH: a 12 month prospective study.
    Erinomo OO; Anunobi CC; Orah NO
    Nig Q J Hosp Med; 2013; 23(2):85-9. PubMed ID: 24579501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.
    De Nunzio C; Kramer G; Marberger M; Montironi R; Nelson W; Schröder F; Sciarra A; Tubaro A
    Eur Urol; 2011 Jul; 60(1):106-17. PubMed ID: 21497433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A clinical analysis of benign prostatic hyperplasia with chronic prostatitis].
    Wu XJ; Yang LY; Zhang XZ
    Zhonghua Nan Ke Xue; 2008 Jun; 14(6):527-9. PubMed ID: 18649752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal association between prostatitis and development of benign prostatic hyperplasia.
    St Sauver JL; Jacobson DJ; McGree ME; Girman CJ; Lieber MM; Jacobsen SJ
    Urology; 2008 Mar; 71(3):475-9; discussion 479. PubMed ID: 18342190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genital and urinary tract diseases and prostate cancer risk.
    Pelucchi C; Talamini R; Negri E; Franceschi S; La Vecchia C
    Eur J Cancer Prev; 2006 Jun; 15(3):254-7. PubMed ID: 16679869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of inflammation in benign prostatic hyperplasia development among Han Chinese: A population-based and single-institutional analysis.
    Hu J; Zhang L; Zou L; Hu M; Fan J; Cai Y; Xu G; Fang J; Ding Q; Jiang H
    Int J Urol; 2015 Dec; 22(12):1138-42. PubMed ID: 26311564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between chronic prostatitis and the subsequent benign prostatic hyperplasia: a population-based national cohort study.
    Lin TY; Chen IH; Weng HY; Lin YC; Ou CH; Li CY; Cheng YS
    World J Urol; 2024 Mar; 42(1):126. PubMed ID: 38460003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of apoptosis and chronic prostatitis in the pathogenesis of benign prostatic hyperplasia].
    Pawlicki B; Zieliński H; Dabrowski M
    Pol Merkur Lekarski; 2004 Oct; 17(100):307-10. PubMed ID: 15690689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.